AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2025
Jan 11, 2025
34576_dirs_2025-01-10_ba455f48-d930-446c-a3da-05aa0928816b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2025-01-09
Reporting Person: DeLucia David (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-09 | Stock Option (Right to Buy) | $0.6508 | A | 525000 | Acquired | 2035-01-08 | Common Stock (525000) | Direct |
Footnotes
F1: The option vests in equal amount quarterly over 4 years measured from 1/9/2025.
More from FIBROGEN INC
Regulatory Filings
2026
Apr 9
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Nov 17
Major Shareholding Notification
2025
Nov 15
Interim / Quarterly Report
2025
Nov 10
Regulatory Filings
2025
Nov 10